ArticleFrontiers in immunology2023

Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.

Reinaldo S Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.